By The Admin
Russia has announced a major medical breakthrough with the successful development of Enteromix, a personalized mRNA-based cancer vaccine that has demonstrated 100 percent efficacy and safety in clinical trials.
The vaccine, which leverages technology similar to that used in COVID-19 vaccines, works by training the body’s immune system to identify and eliminate cancer cells without causing serious side effects.
Health authorities confirmed that Enteromix will be made publicly available beginning tomorrow and will be administered to patients at no cost.
Medical experts have described the development as mankind’s most advanced step in the global fight against cancer, which remains one of the deadliest diseases worldwide.
